Vol 11, No 2 (2017)
Review paper
Published online: 2017-10-12
Palliative care for people with neurological disease
Medycyna Paliatywna w Praktyce 2017;11(2):41-47.
Abstract
Palliative care is developing for people with neurological disease. This may be integrated early in the disease progression, and may have a variable input over time. The careful assessment and management of all issues — physical, psychological, social and spiritual — provides the patient and family the opportunity to maximise quality of life. This requires a multidisciplinary approach and close collaboration with other services.
Keywords: neurologypalliative caremultidisciplinary careethical issues
References
- World Health Organisation. Global burden of neurological disorders: estimates and projections in Neurological disorders – public health challenges. Switzerland, 2006.
- Shaw C, Quinn A, Daniel E. Amyotrophic lateral sclerosis / motor neurone disease. In: Oliver, D, Borasio, G & Johnston W. [eds]. Palliative Care in Amyotrophic Lateral Sclerosis – From Diagnosis to Bereavement. Oxford University Press, Oxford 2014.
- Oliver DJ, Borasio GD, Caraceni A, et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol. 2016; 23(1): 30–38.
- World Health Organization. Palliative care 2002. www.who.int/cancer/palliative/definition/en/ (2002).
- Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010; 363(8): 733–742.
- Youens D, Moorin R. The Impact of Community-Based Palliative Care on Utilization and Cost of Acute Care Hospital Services in the Last Year of Life. J Palliat Med. 2017; 20(7): 736–744.
- Edmonds P, Hart S, Vivat B, et al. Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Mult Scler. 2010; 16(5): 627–636.
- Higginson IJ, McCrone P, Hart SR, et al. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage. 2009; 38(6): 816–826.
- Veronese S, Gallo G, Valle A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care. 2017; 7(2): 164–172.
- Solari A, Giordano A, Patti F, et al. PeNSAMI Project. Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis. Mult Scler. 2017 [Epub ahead of print]: 1352458517704078.
- Oliver D, Watson S. Multidisciplinary Care. In . (Editor): End of Life Care in Neurological Disease. London. Springer 2012, pp. : 113–127.
- Aridegbe T, Kandler R, Walters SJ, et al. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14(1): 13–19.
- Turner-Stokes L, Sykes N, Silber E, et al. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions. Clin Med (Lond). 2007; 7(2): 129–136.
- Aoun SM, Breen LJ, Howting D, et al. Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better? Amyotroph Lateral Scler Frontotemporal Degener. 2016; 17(3-4): 168–178.
- Aoun SM, Breen LJ, Edis R, et al. Breaking the news of a diagnosis of motor neurone disease: A national survey of neurologists' perspectives. J Neurol Sci. 2016; 367: 368–374.
- Buecken R, Galushko M, Golla H, et al. Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues? Patient Educ Couns. 2012; 88(2): 318–324.
- Jox RJ, Krebs M, Bickhardt J, et al. How strictly should advance decisions be followed? The patients' opinion. Palliat Med. 2008; 22(5): 675–676.
- Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006; 5(2): 140–147.
- Oliver D, Faull C. Non-invasive ventilation in amyotrophic lateral sclerosis/motor neuron disease. Minerva Pneumologica. 2013; 52: 27–38.
- Faull C, Rowe Haynes C, Oliver D. Issues for palliative medicine doctors surrounding the withdrawal of non-invasive ventilation at the request of a patient with motor neurone disease: a scoping study. BMJ Support Palliat Care. 2014; 4(1): 43–49.
- Faull C, Oliver D. Withdrawal of ventilation at the request of a patient with motor neurone disease: guidance for professionals. BMJ Support Palliat Care. 2016; 6(2): 144–146.
- Lee M, Walker R, Hildreth T, et al. A Survey of Pain in Idiopathic Parkinson's Disease. J Pain Symptom Manage. 2006; 32(5): 462–469.
- Oliver D. The quality of care and symptom control--the effects on the terminal phase of ALS/MND. J Neurol Sci. 1996; 139 Suppl: 134–136.
- Higginson IJ, Hart S, Silber E, et al. Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care. 2006; 22(3): 158–165.
- Oliver D. Opioid medication in the palliative care of motor neurone disease. Palliat Med. 1998; 12(2): 113–115.
- Scott A, McPhee M. Multidisciplinary care: speech and language therapy. In: Oliver D, Borasio GD, Johnston W. Palliative care in amyotrophic lateral sclerosis- from diagnosis to brereavement. 3rd edition. Oxford University Press 2014: 215–232.
- Smith S, Wasner M. Psychosocial care. In: Oliver D, Borasio GD, Johnston W. Palliative care in amyotrophic lateral sclerosis – from diagnosis to brereavement. 3rd edition. Oxford University Press 2014: 145–170.
- Lambert R. Spiritual care In: Oliver D, Borasio GD, Johnston W. Palliative care in amyotrophic lateral sclerosis- from diagnosis to brereavement. 3rd edition. Oxford University Press 2014: 171–186.
- Pereira SM, Fonseca AM, Carvalho AS. Burnout in palliative care: a systematic review. Nurs Ethics. 2011; 18(3): 317–326.
- End of life care in long term neurological conditions: a framework for implementation. National End of Life Care Programme 2010.
- Hussain J, Adams D, Allgar V, et al. Triggers in advanced neurological conditions: prediction and management of the terminal phase. BMJ Support Palliat Care. 2014; 4(1): 30–37.
- Campbell CW, Jones EJS, Merrills J. Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis. Clin Med (Lond). 2010; 10(3): 290–292.
- National Institute for Health and Care Excellence. Care of dying patients in the last days of life NG31. National Institute for Health and Care Excellence 2016. www.nice.org.uk/guidance/ng31 (2016).
- O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ. 1992; 304(6825): 471–473.
- Neudert C, Oliver D, Wasner M, et al. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001; 248(7): 612–616.
- Agar M, Currow DC, Shelby-James TM, et al. Preference for place of care and place of death in palliative care: are these different questions? Palliat Med. 2008; 22(7): 787–795.
- O’Brannagain D. An integrated framework of early intervention palliative care in motor neurone disease as a model to progressive neurodegenerative disease. 2009, Turin.
